Kymera Therapeutics
KYMR
KYMR
180 hedge funds and large institutions have $2.89B invested in Kymera Therapeutics in 2024 Q4 according to their latest regulatory filings, with 33 funds opening new positions, 60 increasing their positions, 60 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
2% more funds holding
Funds holding: 176 → 180 (+4)
0% more repeat investments, than reductions
Existing positions increased: 60 | Existing positions reduced: 60
12% less capital invested
Capital invested by funds: $3.27B → $2.89B (-$383M)
Holders
180
Holding in Top 10
9
Calls
$3M
Puts
$704K
Top Buyers
| 1 | +$27.7M | |
| 2 | +$26.1M | |
| 3 | +$23.9M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$14.6M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$14.1M |
Top Sellers
| 1 | -$28.4M | |
| 2 | -$11.8M | |
| 3 | -$11.2M | |
| 4 |
Morgan Stanley
New York
|
-$9.99M |
| 5 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$9.74M |